Yatharth Hospital & Trauma Care Services Limited (NSE: YATHARTH) Q1 2026 Earnings Call dated Aug. 06, 2025
Corporate Participants:
Unidentified Speaker
Yatharth Tyagi — Whole Time Director
Pankaj Prabhakar — Chief Financial Officer
Amit Kumar Singh — Group Chief Executive Officer
Analysts:
Unidentified Participant
Aman Vishwakarma — Analyst
Aman Jain — Analyst
Himanshu Mali — Analyst
Dhruv Maheshwari. — Analyst
Harsha — Analyst
Suman Gupta — Analyst
Presentation:
operator
Ladies and gentlemen, good day and welcome to the Q1FY26 conference call of Yatas Hospital and Trauma Care Services Limited hosted by Philip Kaplan PCG desk. As a reminder, all participant lines will be in the listen only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing Star then zero on your touchstone phone. Please note that this conference is being recorded. Let me draw your attention to the fact on this call. Company’s discussion will include certain forward looking statements which are predictions, projections or other estimates about future events.
These estimates reflect management’s current expectations about the future performance of the company. Please note that these estimates involve several risks and uncertainties that could cause company’s actual results to to differ materially from what is expressed or implied. I now hand the conference over to Mr. Aman from Philips Capital India Private Limited. Thank you. And over to you sir.
Aman Vishwakarma — Analyst
Thank you. Good morning everyone. On behalf of Philip Capital Driven Client Group, I welcome you all to the Q1 FY26 earnings conference call of Yatah Hospitals and Troma Care Services Limited. From the management we have Mr. Yathak Jagi, Full Time Director. Mr. Amit Kumar Singh, Group Chief Executive Officer. Mr. Nitin Gupta, President Finance and Chief Operating Officer. Mr. Pankaj Prabhakar Group Chief Financial Officer. Mr. Mr. Ashutosh Kumar, Jha Group Chief. Strategy M&A NIR and Mr. Somu Goyal, Group Finance Controller. I now hand over the conference to Mr. Tyagi for his opening remarks. And we will then open the floor. For the question and answer sessions. Over to you Mr. Tan. Thank you.
Yatharth Tyagi — Whole Time Director
Good afternoon and a very warm welcome to hospitals and trauma Care Services Limited. Earnings conference call for the quarter ended June 30th. Joining me today, Mr. Amit Kumar Singh, Group CEO Mr. Pankaj Prabhakar Group CFO. Mr. Nitin Gupta, Group CEO and President Finance. Mr. Ashutosh Kumar, Jha Group Chief Strategy M and A and Investor Relations. And Mr. Sonu Goyal, Group Finance Controller. Our earnings presentations has been uploaded to the stock exchange and is also available on our website. We hope you have had a chance to review it. I’m pleased to report another quarter of stellar performance achieving our highest ever revenue and profitability.
Our revenue grew 22% year on year while net profit surged by 38% year on year, reflecting the strength of our strategic initiatives and operational excellence. A key highlight this quarter was the greater Faridabas facility which turned net profit positive in quarter one. Within just one year of operations it contributed rupees to 234 million in revenue, accounting for approximately 9% of our total revenue. This rapid turnaround underscores our capability to ramp up and optimize new assets effectively. Looking ahead, our new hospitals in New Delhi and Faridabad with a combined capacity of 700 beds will further accelerate growth from from quarter two FY26 onwards.
The New Delhi facility was inaugurated in mid July 2025 and the Saridabad facility is scheduled for inauguration in late August 2025. Both the facilities are being equipped with cutting edge technologies including robotic surgery equipment and state of the art diagnostic infrastructure. We are also onboarding leading super specialists which will enhance our clinical strength and brand equity in these regions, the latest of which is Pediatric Cardiology team which will be the first in Noida region which is already taking great strides in the treatment of complicated pediatric cases. Our commitment to clinical excellence was demonstrated by several complex cases handled this quarter such as an 11 year old girl from Tajikistan initially misdiagnosed with lymphoma, was correctly diagnosed with hemoma.
At our facility. Our team successfully removed a 2.5kg tumor through a combined cynotomy and throatotomy. In another case, a 33 year old woman with advanced lymphoma and multiple organ complications was treated with intensive care diagnosis dialysis chemotherapy by our oncology team. She achieved complete remission and is now on maintenance therapy with no signs of the occurrence of tumor. These cases highlight her clinical capabilities, advanced infrastructure and growing reputation as a leading coronary care provider in the region. We continue to focus on improving our case mix and payer mix. Supported by strategic investments in Super Specialty Services.
We have made significant progress in our medical value travel initiatives. Recently we have collaborated with the Children Heart Fund and Bragg Lion Hospital, the largest government hospital in Utopia, paving the way for a patient transfer program. We also conducted continued medical education program on IVF in Mauritius along with patient screening to identify potential treatable cases. We are preparing to open an information center in Baghdad as well. Additionally, we are working with Chinnor Medical center in Tashkent to establish a representative office serving as a hub for medical value travel for countries such as Uzbekistan, Tazakistan, Turmericistan and Kazakhstan.
These initiatives are expected to drive medical value travel and contribute meaningfully to overall growth in the coming years along with improvement in operating and financial metrics. We’re also pleased to report the resolution of the Jhansi land issue. During the quarter, the Commissionate of Sagar Sambhav, Madhya Pradesh, following the direction of honorable High Court of Madhya Pradesh, had set aside its earlier order challenging our ownership over the land. This outcome brings legal clarity, reaffirming our ownership and ensuring operational continuity. We are also in the process of transitioning our statutory auditors with our current auditors resigning in this board meeting, we will propose the appointment of well reputed firm MSKA and Associates, a member of BDU International at the upcoming agm.
This, in line with a commitment to strong governance practices, underscores our vision for a strong and transparency to all our stakeholders as we move forward. We remain focused on strategic expansion to strengthen our presence in North India, clinical excellence and continued investment in advanced medical technologies. We are confident that these efforts will continue to deliver superior healthcare outcomes and create a long term value for all our stakeholders. With that, I would now like to hand over the call to Mr. Pankaj Prabhakar, our CFO for a detailed financial update.
Pankaj Prabhakar — Chief Financial Officer
Good afternoon everyone. I am pleased to report that Yathat Hospital has continued its journey of accelerated growth delivering a strong result for the quarter ended June 2025. During Q1FY26 we achieved a revenue of Rupees 2,578 Million reflecting a 22% YoY and 11% quarter over quarter growth. This performance was driven by higher occupancy rates as well as improvement in Arpo supported by our strategic focus on super specialty services and operational excellence. Our newer hospital lead the growth with Jhansi Ocha Hospital reporting a significant 63% year over year increase contributing 7% of total revenue. The Greater Faridawad facility which got operationalized in May 2024 has ramped up well and now accounts for 9% of total revenue.
We witnessed a strong patient volume growth in the quarter in patient volume surged 27% year over year and odd patient volumes rose 20% year over year reflecting the growing trust in our services and the effectiveness of our outreach and engagement initiatives. Our focus on high value super specialty services has resulted in a 6% year over year increase in the ARPO reaching a record of rupees 32,395 for quarter one FY26. Notably, Noida Extension achieved an RPOB of rupees 39,830 with 70% contribution from Super Speciality Services. Our greater Noida facility reported an RPOB of Rupees 38,377, up 9% year over year.
Notably on closing up continued 17% of Noida extensions revenue and 10% of the group’s revenue, making an 49% year over year increase. On the profitability front, EBITDA rose 20% year over year and 13% quarter over quarter to rupees 645 million demonstrating 13 consecutive quarter of growth. ETA margin improved by 41bps sequentially and stood at 25% despite higher depreciation due to ongoing expansion and investment in advanced medical equipment. Our new net profit has grew 38% year over year and 9% quarter over quarter reaching to rupees 420 million. Our balance sheet position stood healthy with a strong net cash position providing us with the flexibility to capitalize on future growth opportunities as they arise.
Looking ahead, we remain optimistic about sustaining our growth momentum in both revenue and profitability. Our strategic priorities will continue to focus on operational excellence, sustainable growth and capitalizing on emerging opportunities in healthcare sector. Thank you for your attention. I would now like to hand over the call to the moderator for question and answer session. Thank you.
Questions and Answers:
operator
Thank you very much. We will now begin the question and answer session. Anyone who wishes to ask a question may press Star and one on their touchstone telephone. If you wish to remove yourself from the question queue, you may press star and two participants are requested to use answers while asking a question. Ladies and gentlemen, we’ll wait for a moment while the question queue assembles. The first question is on the line of Amain Jain from Lucky investment. Please proceed Mr. Amay as there is no response from the current participant.
Aman Jain
Yes sir, this is a small correction. This is Somil. That was the confusion but thank you for the opportunity and congrats on good side of number. Sir, can you lay out IPOBs in. In the new hospitals and the status on the upcoming hospitals.
Amit Kumar Singh
So for upcoming hospital for Delhi as we have stated earlier, this will be our be better than probably what at the current hospital Noda and Britain order which we are operating as of now so that you can. You can, you know, figure it out. For a further work I would say that’s that’s going to be a line of what node accents and is operating as of now. So this is what the archive is concerned. And as far as for the already started new hospitals which was your earlier question that is for the greater Faridabad. The RPOP that we currently have is. Around. 31,393 for the quarter one. And you know as Mr. Masing mentioned the upcoming two new hospitals which would be starting, the Delhi hospital has actually started last month and the Freer hospital will be starting late of this month. We do expect RPOP there to be more than our group average performance.
Aman Jain
Okay. And what about Jhansi sir, you mentioned there was 60% year on year growth. How much did the RPAP rise here?
Amit Kumar Singh
As we have stated earlier as well the Jansi going to be the remain on the R Corp will not be a change. Has a volume growth. Right. The dhancy will be in a line of close to 15,000. I think that is what I think we are reaching there. 14,000 something. 14,000 I think as of now I think yeah, 13,500 something. So anything between you know closer to 15,000 to the best case scenario of you know 16, 17,000 that will be. I think it will be a pleasing number for us.
Aman Jain
Right. Okay. And two more questions are one, on the tax timeline for the new hospitals, are we on track?
Amit Kumar Singh
Yeah, as I just mentioned.
Aman Jain
Secondly on the margins for the full year you mentioned you expect it to. Remain around the same levels as quarter four for the entire FY26. Are we on track for that as well?
Amit Kumar Singh
Yeah. So the upcoming new hospitals as I mentioned Delhi has already started got operationalized. So it’s a revenue will start flowing from the month of August as we speak. And the bigger hospital In Faridabad, the 400 bed hospital we are planning to operate inaugurated late August. So the revenue for those these two hospitals you will start seeing from quarter two onwards. So we are pretty much on track for that as far as the margins are concerned with the operation of these two hospitals. Yes, we do expect, you know these two hospitals there would be certain drag on the EBITDA margin compared to the whole of FY25.
But quarter four of FY25 would be a right analysis to compare the margins and probably a percent up and down from the quarter four would be the right estimation for these two hospitals. Now starting for the overall group.
Aman Jain
Okay. When do you expect these two new hospitals to reach break even?
Amit Kumar Singh
Sir, if we talk about if you look at greater Faridawad hospital that you know got operationalized 12 months ago, that hospital has in the latest quarter now become profit positive. So which is we feel is a good achievement for any hospital starting operations within 12 months of it. So. So we do expect probably these two hospitals to follow a trend somewhere around 15 months would be a right estimation for these two hospitals also.
Aman Jain
Okay, got it right. That’s it for myself. Thank you so much and all the best.
operator
Thank you. The next question is from the line of Himanshu Mali from Walford pms. Please proceed.
Himanshu Mali
Hello sir. Congratulations for the good set of numbers. I have two questions. So my first question is what is the share of MVT now and how it will look in future. And the second question is the share of dialysis and chemotherapy now and how it will look in further quarters.
Yatharth Tyagi
Okay, so as far as first question is for the medical value added tourism. So you know, international patients is something that we have recently started catering to because if you look at Delhi NCR international patients come for high end treatments like oncology, radiation oncology, liver transplant, bone marrow transplants. These are the programs that we have just started over the course of last one and a half years. As soon as we have started these treatments, we have seen a good flow of these patients. Now you know, as I mentioned in the commentary itself that we have tied up and opened up, you know, various offices across the CSF countries.
There’s some hospitals that we have tied up there. So we are seeing good step up in the volume as the contribution of medical tourism is concerned. And your second question on the chemotherapy aspect, I think we would in a large way to generalize it how we look at it in terms of oncology. Because you know, not just chemo but the whole radiation oncology, the surgical oncology as well as the bone marrow transplant, we have placed strong emphasis on that and we are quite happy to see that year on year we have shown 50% growth in our oncology business.
And oncology is now contributing close to 10% for the overall group. We do expect this number to even go higher because remind you that our upcoming hospitals, both the Faridabad as well as the Malltown hospital within few months will also be having radiation oncology. So these two hospitals will also act as oncology feeders for the whole group. And the 10% radiation oncology that is for the complete oncology that is today for the whole group can even grow around 15% in next couple of years as well. The total PM is concerned.
Himanshu Mali
Okay. Okay, thanks. Thanks. That’s from myself.
operator
Thank you. The next question is from the line of Dhruv Maheshwari. Please proceed.
Dhruv Maheshwari.
Hi from perpetuity. So just wanted to understand that the greater Noida Hospital is the occupancy has been for years have been around 60, 65% and Noida extension also seems to be plateauing at an occupancy of 61. So do you see a breakthrough in this? That would be my first question. Secondly, wanted to understand that the Noida Hospital had a 79 occupancy in quarter four has gone up to 86 seconds. So quite a huge jump. So like what was the factors contributing to this and has the. Have we been improving the payer mix as well and the third would be on the other income and the tax increase.
Amit Kumar Singh
So as far as your first question is concerned, Greater Noda and the Noda extension has a occupancy almost similar what. We had last year. But what you need to look at it. Well the mentioned in the commentary, what is the IPD numbers? If you see that has increased. So your LOS has decreased. So the we have treated more patients however because of the los and that is a deliberate attempt. As we had said in a weather in a previous quarters, we are trying to sanitize our, you know, the paired mixes. Right. So these are the impact of it. However, I think that this percentage we are very much satisfied with the greater NoDaDa with the 67% of occupancy and node adjacent with 61% the totality numbers if you see the IPD numbers we have treated more. That’s first. I mean answer of your first question. Second question is about Noda. Yes, Noda occupancy has increased significantly increased. But the numbers if you see as we had mentioned earlier, the earlier number, if you see and now you see the cash TPA Noda has done, Noda is doing better. This was a deliberate attempt as we said earlier.
So we are reducing bit of dependency on the government. So the cash TPA and then you know the specialty mixes also has gone better. So this is what the thing as. Far as your third question on the other income is concerned. So the other income that you see for this year is basically the interest the company has received on the certain FDS that we were having both from the QIB fund that we raised as well as certain intel accuracy we had. So you know, over the course of upcoming quarters that will also be generalized. But for this quarter, yes, there was a other income received due to the interest that we have received on the fds.
Dhruv Maheshwari.
Okay, so what is your payer mix currently?
Amit Kumar Singh
So as far as the payer mix is concerned, you know, as we’ve always maintained that we are reducing our government business. Government business which you know, a year and a half ago used to be somewhere around 40% as we speak today in the latest quarter of Q1 it is around 35% and the remaining is, you know, equally divided between the cash as well as private insurance. With private insurance being bit more in terms of the volumes but in terms of the revenue cash component might be a bit more. And you know we are seeing good growth in our international patient flow as well.
We are quite confident that maybe with all these, you know, steps that we have taken in medical valley tourism, with the airport opening up with now, you know, these new leading star doctors on our board, we feel international pyramids can even touch close to double digit numbers in a couple of years for the whole group.
Dhruv Maheshwari.
That’s good to hear. And just lastly, what is your net catch on the book.
Amit Kumar Singh
Today? You know we would be upwards of around 300 crores. You know and when we closed the last financial we were close to 500. So the amount that has been spent has been on the equipment front or in the upcoming two new hospitals of the Delhi hospital as well as the Frida Bal hospital.
Dhruv Maheshwari.
Okay, thank you.
operator
Thank you. The next question is from the line of Harsha from seven Seven Rivers Holdings. Please proceed.
Harsha
Hi sir. Good afternoon. And a strong start to Q1. So just wanted to reiterate, you mentioned that the impact on ebitda from the two new hospitals I.e. Delhi and Faridabad will be hundred this right. And it will get neutralized by Q4. So Q4 FY26, they should be back. To 25% EBITDA margin.
Amit Kumar Singh
Yeah, I think rather than seeing quarter on quarter how we see it for the full year we feel, as I mentioned, EBITDA margin would be somewhere close to what we had in Q4. Maybe a percent up and down. That’s how we are looking at it. And Q1, you know we also saw a good EBITDA percentage as well as good EBITDA growth. Because the greater Faridawad hospital has become also a bit of positive. So the drag that the greater Faridabad hospital had last year will not be having this year. So even though we have two hospitals operationalizing, we also have one hospital who is now turning EBITDA positive for the year.
Harsha
Okay. And sir, how should we look at these two new hospitals in terms of. If I look at Q4, FY26 exit. Run rate, what kind of occupancy do. We expect and what kind of payer mix will this new hospital have? Because I believe the government dependency might. Be low in this newly commenced hospital. So what kind of payer mix do we expect? What kind of occupancy do we expect say on Q4, FY26 exit run rate.
Yatharth Tyagi
Basis again rather than quarter quarter. How we feel is that after first year of operation, you know, so technically they are starting in Q2, so the right estimation would be a year from Q2. We do expect both these two hospitals to have an occupancy somewhere around close 30 to 35%. And that’s what you know, our existing other new hospitals have also had. But as far as the payer mix is concerned, yes, you’re right there would be a very less government business similarly to what we have already proven in the greater Faridawal Hospital. Because that’s also a reason why, you know, the hospital has achieved good numbers because the dependency on government business is very low there.
We have hired a lot of star doctors also in that region. So we do expect for these two hospitals on a similar line, maybe government business should not be more than 20, 24% in these two hospitals going forward.
Harsha
And sir, on FY26 as a whole, do we still expect our RPO to increase by 10%, say for FY26 as. Well as FY27 on blended basis? Yeah.
Amit Kumar Singh
So it’s not that anything as we have said anything between 8 to 10%. That’s I think the ARPO growth which you are looking at. So we have all the drivers. So I think we believe that. I think this will be easily achievable.
Harsha
And so last question, any, any update on the income tax investigation that you would.
Amit Kumar Singh
As we were in Q4, the the company is quite happy with the progress in the income tax matter. It is a status quo from Q4 I.e. eKS, which is a very large subsidiary of the company contributing close to around 40% of the revenue. The income based audit is largely being completed and and there’s a minuscule demand that has been arise and in the coming time we would be looking to pay that and settle that off as well. As for the whole remaining companies concerned, we do expect, you know, somewhere close to the end of this calendar year that also will be completed.
And as we’ve always maintained, you know, before this closing of the financial year or somewhere close to the end of the calendar year, we would be completely looking to settle off the complete matter and whatever amount that would be required at all would be company would be very, very capable of handling ad and it would be a very small amount that we were anticipating in that matters concerned.
Harsha
And if I can squeeze in just one last question, if you can share the status and timeline on the brownfield expansion at our greater Noida and Noida extension of this.
Yatharth Tyagi
Yeah. So you know we have just started two new hospitals. That is the New Delhi hospital and the Frigal hospital that we have just recently starting now this month. So the more focus was there in ramp up these two hospitals. Now that these two hospitals are started, we are shifting back our focus to finish up a brownfield expansion. A greater Noda hospital is already at a commencing infra stage. That means the construction is you know about to start for the digging of the basement creating all the flows up. As far as not extension is concerned, we are at finalizing stage for the maps for the whole building.
Both 200 and 250 beds will be added in these two hospitals. And the timelines remains largely similar maybe two, three months up and down. But however for last quarter we were more focusing on the Delhi in the federal hospitals. The brownfield expressions is now again back into the focus for the quarter two.
Harsha
All right, thank you so much and all the best.
operator
Thank you. The next question is from the line of Suman Gupta from Centrum. Please proceed.
Suman Gupta
Hi, good afternoon. I’m audible. Yeah, so first question is on the case wave. So just want to understand so like what is the trajectory over the next two to three years where we can see encore share rising from current 10% and its medicine share declining. So can we expect that to increase?
Yatharth Tyagi
Yeah, so in fact Sumit, you see the future trends going to be as encore definitely going to increase that. You see the, you know there are other transplants and high end procedures will increase. Right. So definitely in terms of the percentage the internal medicine conservative will be a down but not the absolute number. Right. Because as we are growing these things. But yes, this is a trend that’s more super sociality particularly leading by the oncology going to be the right thing. And I said we are not a matured. All these departments are not matured Sumit as of now. So as we said that quarter and quarter in fact every super departments are growing. Right. But yet the faster growth coming from the oncology.
Suman Gupta
Yeah, I’m talking from two to three years down the line. So a bigger picture. So in medicine let’s say as of now it is contributing around 20%. 18 to 20. So can it go to around 10, 11.
Yatharth Tyagi
But I think that the internal medicine medicine is very, very important because medicine can feed all super sexuality. So you know reducing medicine is also not a smart move. Right. So we have, there has to be a good balance. So I believe that if medicine is. Contributing around 15 to close to 15%. 17%. I think that’s a fairly good number. Right. Because that, that works as a feeder for a super sociality. Understood.
Amit Kumar Singh
And down the line what we are focusing is on improving on all the cognitive specialities cardiac or ongoing ortho and neurosciences.
Suman Gupta
Understood, thanks. And with respect to the depreciation, how should we look at, look at it? Shall we expect it to be at the same time or should we see for the next two years?
Pankaj Prabhakar
For next two years now as we are adding two more facilities so that will definitely impact but the impact is not so much. So we can presume around 20, 30 million impact quarter on quarter on a total basis.
Suman Gupta
Okay. Okay. And for the next three years how much of. Can you repeat the question? Cumulative capex for the next three years.
Yatharth Tyagi
So cumulative CapEx would be for the next three years would be in the tune of. If you include both Brownfield as well as Greenfield it would be in the tune of around 1400-1500 crores over the next three years.
Suman Gupta
And how much would be maintenance?
Yatharth Tyagi
Maintenance is a low capex for us. Maintenance is actually not included in this. Maintenance for the whole year should be around 20 to 25 cr for us. We have already ramped up our hospital in the recent past and all the kind of a new equipment was already in place. Just a few field work has to be there. As we mentioned about the Brownfield expansion as well. So that’s the only thing which will be coming up. Rest of the team has been already filled in all the centers.
Suman Gupta
Understood. Thank you. All the best.
operator
Thank you. The next question is from the line of Nirali Shah from Ashika Talk Services. Please proceed.
Unidentified Participant
Yeah, thank you for the opportunity. I had a couple of questions. I just wanted to know is there any update on the Gabad Greenfield opportunity? And he’s also evaluating two, three more cities. Has there been any progress on those fronts?
Yatharth Tyagi
You know as you are right we are evaluating not just Gazebad, we are evaluating other opportunities within NC here, Ghazibad, Gurgaon, you know, outside NCR also big cities basically. And the company would be looking to add at least one, you know, acquisition for this year. Maybe it could be a greenfield land, it could be a stress asset. The company is evaluating certain opportunities and we remain confident for the remaining of the FY26 we will be adding and closing one of these opportunities.
Unidentified Participant
And what kind of investment are we looking at this number and indicated?
Yatharth Tyagi
Yeah, so for a Greenfield, you know, including the land we are looking to add around, you know, 300 to 350 grids and including land I think the total capex outlook that we see is around 300 crore.
Unidentified Participant
Okay. And just wanted to know the effective tax rate for the quarter is higher than usual? Yes, it’s around 28%. Are there any specific adjustments this quarter or should we still assume a full year EPR as I did earlier to be around 24%.
Yatharth Tyagi
If you see the current exit is coming around 28.32%. Okay. And there is a. There is not an adjustment because there were some earlier they were deferred in our Ram City hospital that is located. In OSHA right now there is a. Debit tax liability that that tune of to total 28% of the overall percentage in a tax rate. So on a full year. No it will come down to 25, 25 26%.
Unidentified Participant
Okay, understood. Thank you. And just the last one on the iPhones. So this quarter is around 30 to 395 and that is likely by three department break even two new hospitals. We were expecting it to be around in the range of 33 to 35,000. Correct?
Yatharth Tyagi
No, it would be a bit more for the two new hospitals it would be somewhere around 38,000. For those two new hospitals that New Delhi as well as the free hospital the bigger.
Unidentified Participant
Understood. So that will change from second quarter.
Yatharth Tyagi
Yes. Most big impact you will start seeing from Q3 onwards because we are midway of Q2 already and foridable is yet to start. So the big impact you should start. Seeing from QC itself on a blended basis for 26. What would be the R Pops? What are. What is the number that we are building? See but it’s not. No, no forward looking number. But I can tell you. You can, you can, you can just you know correlate as of now you see the greater Noda Noda extension is in a line of 40,000. Close to 40,000 ARPO. Right. As you said that that’s Faridabad and Delhi would be doing. Delhi would do a bit more and the federal would be in a line of this thing. So this is what I think I can tell you. I just know.
Unidentified Participant
Understood. Thank you.
operator
Thank you. Ladies and gentlemen. In order to ensure that the management is able to address questions from all the participants in the conference please limit your questions to two per participants. The next question is from the line of Aditya Sen from Findong. Please proceed.
Unidentified Participant
Hello. Hi. Thanks for the opportunity. I’m audible right? Yeah. So this is regarding the international patients that you are targeting. So as we added to the double digits as a percentage of your. Of our total patient makes, will there also be any additional cost associated with the procurement of international customers?
Yatharth Tyagi
So typically as of now we are a single digit number. And then. So what do you need? You need a. Basically that the good team team has already been added. Right. So the. When you start doing the. Your, you know, various information center, you’re setting up various information centers on different place. So there’s all the opex. Right. And then definitely if you lean international and you understand that the arpob is better so. Right. I think that’s only the OPEX will be. I think there is no other capex as it’s neither even a manpower cost. It’s already been taken care of now. Yeah. And we do not see any impact on our profitability or EBITDA due to increase in the international patients. So technically it will not increase or change any of our parameters once the international business increases. In fact it will better our R POP numbers because all the expenses mostly have been done in terms of hiring the doctors, getting those, you know, equipments in place and starting those treatments. Now just the volume has to grow.
Unidentified Participant
Understood. So I was asking this question particularly because there is a competitor of ours in Gurgaon who has a higher RPOB because of international patients. But the EBITDA margin is way low than our EBITDA margins. So I was just afraid that if we are adding international we might not fall back to their levels of ebitda.
Yatharth Tyagi
Difference between that context and us is that we are not just single handedly focusing on international patients. You know, one third of the revenue comes from cash patients, one third comes from private insurance and certain still comes from government. We will not make, you know, international patients contribution to 1/3 of our revenue. So that’s the difference. It will still be close to around 10% which is how a lot of hospitals, other hospitals also operate on.
Unidentified Participant
Okay, fair enough. Got my answer. Thank you.
operator
Thank you. The next question is from the line of Bhagwat from Prosperity Wealth Management. Please proceed.
Unidentified Participant
Thank you for the opportunity. Considering the operation operationalization of two new hospitals, what is the estimated revenue growth on a consolidated level for current year and next year? FY27.
Yatharth Tyagi
Our revenue growth expectations for the whole year remains the same. Our guidance remains the same as we have always maintained that, you know, last few years the company has grown close to around 30%. I think in the upcoming years also including this year, we remain on track for that.
Yatharth Tyagi
Okay. Similar ranges, 30% you can expect. Hello? Yes, I think I got my answer. You’re saying 30% votes can be estimated. Hello. Yes. Yes.
Unidentified Participant
Okay. Thank you. Thank you.
operator
Thank you. The next question is from the line of Surya Narayan Nayak from Suniti Security. Please proceed.
Unidentified Participant
Yeah. Thank you for giving me opportunity. Congratulations for the gift set of numbers. Just one question is that how are you going to phase out the addition of new birds in the new Foridabad 400 and daily 300 units. Because the facility is saying, you know, we have added 300 beds. So can we assume around 250 census beds from the Q2 onwards? Likewise. Can you please guide for the Faridabad unit also?
Yatharth Tyagi
Yeah. So you know, whenever we starting a hospital, you know, the beds become operational on a scale basis. But you know, it is not that we have restricted to any beds we might operationalize. Like the Delhi hospital, you know, we just inaugurated today. We can have officialized close to 150 beds. But if we get 151 patients today, it’s not that that patient would be refused for admission. So the scalability of the beds is there as and when required. You know, the infra is ready, the nurses are there, the equipments are there as and when the patients are coming.
We will look to add up and scale up those flows. So even from day one we are starting the hospital with complete infra. It’s not that, you know, certain flows are not ready or certain construction is going on in the del hospital, everything is complete. So similarly to what we did in the greater Faridawad hospital, we would be ramping up our census beds and operational beds on a similar manner.
Unidentified Participant
Okay. And sir, for the Noda extension, greater Noda extensions, the current occupancy is, you said similar to that. So can we expect what would be the expectation for the peak occupancy in these regions? In the NCR especially, you know, can it go to 75 or 80%.
Yatharth Tyagi
Noda Extension Garden ODA is a above 400 bed facility. So if anything 75 to 80 there’ll be a very, very ideal and very optimal utilization. I think beyond that it’s difficult. So I think that’s we are inching towards it. So anything 75 to 80 can be. You know, guidance and certain drivers are there for this which we are quite confident that in the coming years, in the coming quarters you will see increase in occupancy in these two hospitals. Specifically, you know, we’ve added a lot of startups. In even these two hospitals. We are starting certain new treatments like the transfer program, the radiation oncology, where the volumes is bound to increase. As well as increases in international patients. So these three are good, you know, drivers for the growth of occupancy also. And we’re quite confident that, you know, in the coming quarters you will see.
That rise in occupancy because you are adding a new even offering. So can we, can we consider that not some of the areas where we have not actually matured or not established and often establishing our cases, maybe in radiation, oncology and other areas we will be getting higher occupancy and not before that. Already. It’s not just the new therapeutic areas we have added. Even in the existing areas like you know, pediatric, ortho, you know, gyne, there are constant upgradation of departments and the new doctors that are added new data doctors are not just adding the new specialties but even our existing specialties, you know. So there also we do expect increase in the volume including general surgeries, including certain other super specialties like gastro, like neuro, that we have been doing since a long time. So we do expect occupancy to grow from all the super specialties. But yes, highest share will increase of the super specialties likes of cardiology, oncology and neurosurgeries.
Unidentified Participant
Okay, can it be fair to assume that we will be beating the inflation in all the NCR region hospitals at least for next three years?
Yatharth Tyagi
Yeah. Because twice in a year we keep on changing our pricing. So by considering the inflation we keep on changing the pricing of the overall patient charges. So we are pretty much sure to beat the inflation.
Unidentified Participant
Okay. And sir, regarding Mr. Surya, may we request you to join the queue as there are other participants waiting for their turn. Okay, thank you.
operator
Thank you. The next question is from the line of prerna from Equity Research Program. Please proceed.
Unidentified Participant
Hello sir, can you hear me? Yeah, yeah. What is the status of empanelling in your New Delhi hospital that you recently inaugurated? Like how is the panelment going with insurance and various other government departments?
Yatharth Tyagi
So you know, we have started taking all the, you know, private cash patients as well as for the private insurances. Now the process is ongoing because you we are getting fast tracked. Our NABH is another QCI permission. As soon as that happens, private insurances will be empanelled and then the number comes from the government empowerments. However, already from day one now there’s a lot of agencies like you know, Credibility, G Money and other aggregators which does provide cashless facility to any private insurance holder who’s walking to a hospital so he’s able to utilize his insurance through those third party aggregators.
And they’re able to get cashless treatments. Similarly, we have done that in the past in our greater hospital and we’re doing that today in a New Delhi hospital. So already we are treating private insurance patients there. As far as the empowerment of these private insurance and government panelments are concerned, I think within the first year we would be able to get 90% of all private insurance as well as the government. But it will not hamper our progress of taking those patients.
Unidentified Participant
Okay, sir. Okay. And the last question is on EBITDA margin. You told you know that because of the starting of this new two new hospitals the EBITDA margin will be similar to Q4 of FY25. So can we expect around that 24% or is it going to be lower than that?
Yatharth Tyagi
Around. That would be a right estimation. A percent up and down but around 24% would be a right estimation.
Unidentified Participant
Okay, sir, thank you so much.
operator
Thank you. Thank you. The next question is from the line of Vicky from Guardian Capital Partners. Please proceed.
Unidentified Participant
Thank you for the opportunity, sir. So my question is what was the. EBITDA and PAD for Greater Hospital for this quarter?
Pankaj Prabhakar
So EBITDA for this quarter in data 1 point that contributes to 1.7% of the overall and as that is 3.4% of the revenue and data.
Unidentified Participant
Okay. And so one more thing I wanted to ask. We have been seeing increase in employee. Cost as we are onboarding new super doctors. When do we expect this to settle down? Because earlier employee cost as a percentage of sales was around 17.17.5 which has increased up to around 19%. So when should we expect this to normalize going forward?
Amit Kumar Singh
So basically as you said, these hospitals like a greater Faridabad, the new hospitals, right. So you see that the percentage the employee cost will be the higher. But yes, when the idea of mature hospital I think it should be anything between 15 to 17%, 18%. It’s an ideal percentage. I think that. I think we should get settled in it.
Unidentified Participant
One more question. These are very early days. But how is the response in Delhi. Hospital that we inaugurated?
Yatharth Tyagi
We started just on the 14th. So I think that the excitement in the market, I think the medical fraternity is very, very busy. They are excited. There are so many, you know, people are coming joining these things. So I think and as I said that we are in that area which is a very old but very, very prominent area of the Delhi. Right? So there we see that. I think this hospital will do a much, much faster ramp up in our group. Thank you, sir.
operator
Thank you. The next question is from the line of Yashmodani from Krunatha Investment Advisors. Please proceed.
Unidentified Participant
Am I audible?
operator
Yes sir.
Unidentified Participant
Yeah. So I just wanted to ask you what are the drivers when the increase in occupancy rate in Gancy also hospitals and what are your projection for next quarters also in terms of arpa if.
Yatharth Tyagi
You see, I mean that has made a very good progress. YNY I think it’s the last date was 45. Now it’s around close to 60%. Right. So Jasi Wasa is doing good as you know that hospital delivering good quality care, the all super specialities, the name getting splitted in that particular market. And then we have advantage of, you know there is no other big hospital in that range of 200 kilometers in that region. So I think that’s as time moving. Yes, bit of impairment also playing a big role. There are slowly the more government impairments are happening in that particular hospital. So within the two years of operation it’s a 60% occupancy. I believe it’s a very good occupancy. And if it’s around close to 70, 75% I think that still optimally will utilize this RCA.
Unidentified Participant
Okay, and my next question sir, how. Do you anticipate the rental of the. Junior hospital and how this will influence the overall occupancy rate?
Yatharth Tyagi
So you know, with the addition of even 700 beds, you know, and they will take time to ramp up because as I said that after first year of both these two hospitals operationalized, we feel that both these two hospitals can have an occupancy close to 30 to 35%. So at a group level, yes. Even though with the addition of 700 significant beds we expect even at then at the group level occupancy should increase because occupancy is bound to increase in existing hospitals of you know, Faridabad as well as the greater NORD and the NORD extension.
Unidentified Participant
Okay, thank you sir.
operator
Thank you. The next question is from the line of Aman from Philip Capital. Please proceed.
Unidentified Participant
So my question is on the Capex. Outlay that you mentioned. So we are currently at 2300 beds and we are about 700 beds from our targeted 3000 number. Right. Now if I look at the Capex guidance that you gave earlier of about 14, 1400 crore, is that number right just to begin with?
Pankaj Prabhakar
Yes, that’s approximately around that. Okay, now if we just roughly do. The math, the Capex per bed comes out to about 1.52 crores per bed. Almost Right. And this is relatively higher than what our historical numbers have been. So is this majorly because do we plan on doing more on Greenfield capex that might drive our cost up? Is my understanding correct? No.
Amit Kumar Singh
So just to correct you there, when I’ve said 1500 crores it is not just to take a bet from 2300 to 300 in next three years we are looking to add around, you know, 1200 beds more. That’s why, you know the capex per bed will come down in the tune of 1 Cr and not in the tune of that. Because there is no benchmark that we have taken that you know we’ll just stop at 3,000 once the growth is there. If we have accelerated our growth, we will continue to grow at the same level in terms of adding of the beds are concerned because there are a lot of good opportunities, you know, that we have seen and we are evaluating them.
It is not that we are chasing a number of beds that we want to be. If a good opportunity is there, we would like to add to it, you know. So that’s why we are evaluating few land parcels. We are evaluating through stress assets. So over the course of next, you know, a year and a half or to two years we will be adding more beds than just 3,000.
Unidentified Participant
Okay, noted. I just wanted to clarify that. Thank you.
operator
Thank you. Ladies and gentlemen. In order to ensure that the management is able to address questions from all participants in the conference, please limit your questions to one per participant. The next question is from the line of Anand from Qezma Wells Private Limited. Please proceed.
Unidentified Participant
Good afternoon sir, can you hear me? Yes sir. Yes. I just want to understand on the brownfield expansion of Greater Faridwad Hospital, would you see a brownfield expansion by how many beds, let’s say in the next four, five years for Greater Faridabad?
Yatharth Tyagi
So Greater Faridabad does not have any brownfield expansion possibilities. You know, that hospital has currently 200 bed. And in fact that is the reason why we have acquired another hospital in Prideabad which is now a 400 bed hospital which is going to start at the end of this month. Maybe the hospital you’re talking about is Greater Noida which currently is 400 beds. And we are doing a brownfield expansion of 200 beds there which will be coming to utilize that capacity within two years.
Unidentified Participant
Okay, but there is no brownfield expression for greater father but at all. Okay. Okay. And I just want to like get an understanding of what would be the census, you know, as a percentage of operations. What will be the census percentage of the new hospitals? Faridabad and Delhi. Sorry.
Yatharth Tyagi
85%.
Unidentified Participant
Sorry, I’m going to repeat again, it’s not very clear.
Yatharth Tyagi
It’s going to be 80 to 85% of the total.
Unidentified Participant
Okay, okay. Okay. And what would be the occupancy rate for these two hospitals as well?
Amit Kumar Singh
As we’ve already mentioned, after a year or so somewhere around 30, 35 would be. Right. Estimation.
Unidentified Participant
Okay, that’s another question. Thank you.
operator
Thank you. The next question is from the line of Mohammed Patel from Edelweiss Public Alternative. Please proceed.
Unidentified Participant
Yeah, hi, I just wanted to have one clarity. So can you break up the capex of 1500 crores?
Yatharth Tyagi
Right. So you know if you look at it, we are already doing a brownfield expansion of Greater Nord and Nord Extension Hospital. So that comes to around 450 beds. Now brownfield expansion that we are doing would be doing at a capex of around 60 to 70 lakh capex per bed. So that is the cost of the brownfield expansion we are doing. Plus I’ve talked about that when we are acquiring a greenfield project, you know, as earlier mentioned, maybe this year around c and x c 50 beds we will be spending around 300 crores for including land for that hospital.
And similarly for any expansion of 300 to 350 beds in the corresponding years also we would be spending 1 crore capex per bed. So that’s roughly how it is. Probably within 1500 crores we would be able to add around 1200 beds additional including the greenfield and the brown seed.
Unidentified Participant
Okay, so this is including inorganic acquisition. Yes. Yes. Thank you.
operator
Thank you. The next question is from the line of Vicky from Guardian Capital Partners. Please proceed.
Unidentified Participant
So thank you again for the opportunity. I just wanted to ask one question. What was the deeper it is for.
Pankaj Prabhakar
The last quarter. So better days for the whole year in FY25 was around 123 days. And I think for the latest quarter also I think we are looking to reduce that somewhere. I think we see by H1 we should be reaching a number of around 118 to 117 days. And I think that is if you’re on that because even our scale is increasing, the volume is increasing. But probably at H1 we would be looking to close around 117 days for the debtors.
Unidentified Participant
Thank you so much.
operator
Thank you. The next question is from the line of Vishnu from Vishnu and family. Please proceed Mr. Vishnu. As there’s no response from the current participant we move on to the next participant. The next question is from the line of Omukant Sharma from Vaishan Ventures. Please proceed.
Unidentified Participant
Yeah. Hi. Thank you for the opportunity, sir. Most of my questions are answered. I just have one quick question. If you could just touch down on your new hospitals, which is your model town and the Faridabad hospital. Could you just talk a little bit about what is the competitive scenario situation in those two areas as to which are the hospitals that we would be competing, which are the hospitals which are there in the catchment area. Could just show some color.
Yatharth Tyagi
Yeah. So as far as Delhi hospital is concerned, within 10 kilometer radius we have a 47 max. But yes, if you see, you know that, that, that’s very, that hospital is very, you know, in the region there is a very high density of the population. Right. So I think the 3, 4 km, 5 km is enough for you to you know, feed a largely the 60, 70% of your the bed capacity. So. And that is what since our competitions are with the Fortis and max and a few smaller hospital there, we are making that hospital absolutely on a quarterly care hospital. So that’s there. But I believe that you know, more and more hospitals in particular region, more and more market develops. I think we are nowhere inferior in that particular market as far as Vaidavar is concerned.
Amit Kumar Singh
Also just to add to the Delhi hospital which is officialized few weeks ago, you know, the name of the competitors that we just mentioned, we have, you know, taken on board some of the star doctors who have been on in those hospitals for last 10 years, last 15 years. So you know, that’s how you know we are positioned at hospital. And in fact how we’re trying to compete is also, you know, we’re trying to create a very boutique hospital culture where every patient who’s entering a hospital is getting care and address to the other hospitals in the region which might be 70 kilometers within a radius.
You know, the patient volume and the patient channel is so huge in those hospitals that patients are sometimes not getting the personal attention that is required. So how we position ourselves is each and every patient that is coming to the hospital will be highly focused on the patient care experience by the same star doctors who have been previously practicing in those regions. As far as Faridawad is concerned, Faridawad is a market we very much understand. We already have a hospital 200 in the official a year and a half ago. So this new hospital, Faridabad that we have is also, you know, there are one public hospital, Chandelabad, it has many big local hospitals which are still not so those hospitals have already been doing well in that region.
In fact, Faridabad if you see is a Older city with much more bigger healthy market than even Noida as of today we speak. So you know there are a lot of opportunities for again similarly from start doctors that we are onboarding in Faridabad. And the good part is we already have a feeder from a greater Farida hospital to feed certain with specialties that we will be doing here which we couldn’t do there like oncology, like transplant program like you know certain of the bone marrow transplants. We already have a feeder from existing hospitals to feed a bigger 400 bed hospital in Hyderabad also.
Unidentified Participant
Got it. Perfect. And just one from a numbers perspective, right. We see that the employee cost has jumped by about 4cr q on q basis is that part can this be related with the operationalization of this new hospital? And also up to the question would be let’s say by year end what would this on a quarterly run rate basis what are the number that we’re talking about on employee cost by the year end?
Yatharth Tyagi
I think I’ve already answered this question. So this business as a new hospital is coming up the percentage, right. If you see this it looks bit higher side of it. But we understand that this gonna be the will remain within the industry practice anything between 15 to 17% 18. That’s what I think that the employee cost and that’s going to settle down as far as doctors daughter cost concerned. I mean that’s also you see because the new hospitals coming up the percentage will increase. But this will be well within the range and we are very much onto it these numbers.
So once this gets mature I think that’s the ideal time when you can you know questions on the this percentage. But this hospitals are not mature this. I mean they just started it. So one or two.
Unidentified Participant
What I’m trying to get a sense. Is this this 48 number when we. Are seeing for the quarter it does. That reflect the entire cost of the greater for the Delhi hospital at least?
Yatharth Tyagi
No, even in the Delhi hospital because you know it has actually been officialized, you know just few weeks back. So in quarter two is when you will see those numbers and they are not reflecting in the quarter one. Is. When the hospital got inaugurated.
Unidentified Participant
Okay, got it, got it. And just one last question. If you could just throw some. If I don’t know if you mentioned. That but if you could just talk. A little bit on the operationalization of. The groundfield Capex that we’re planning. When are we seeing that to be getting operationalized?
Amit Kumar Singh
You know the greater Noda hospital should be before the two years and and not extension should be around two years from today.
Unidentified Participant
Okay, perfect. Thank you. Thank you very much.
operator
Thank you. Next question is from the line of from LED advisors. Please proceed.
Unidentified Participant
Hello, this from my question is that any on the target of a of 3000 beds by FY28, since you have managed to add new beds faster, do we see this target to be achieved sooner than this? And also beyond this 3,000, say five years ahead? What do.
Yatharth Tyagi
Definitely, you know, we are looking to expand because as earlier mentioned that we are not just looking to expand it anymore. You’re looking to expand because there is some good opportunities there that we’ve identified which are present in the geographies where we operate, where we feel that we can have even first more advantages by being present in those geographies. So 3,000 target. Yes, definitely looks like it might be met before the FY28 target. But even beyond that, for a five year horizon, we would be looking to scale up at a similar trend to what we have scaled up in last two years.
So we would like to continue the same momentum as to how many beds it will leave after five years. Time will tell, but the momentum should be continuing at least within the North India market.
Amit Kumar Singh
We are not chasing any, you know, particular targets in terms of number of beds. So as and when good opportunity comes, we will be, you know, scaling ourselves.
Harsha
Okay.
operator
Thank you. The next question is from the line of Anand Kulkarni from Current Wave Resort. Please proceed.
Unidentified Participant
Hi, thank you for the opportunity and congress on a great set of numbers. Most of my questions have already been answered. So just one. On the specialty charges. As our share of Congo in total revenue continues to rise, how are we looking at our specialty charges as a. Percentage of Congo having couple of years down the line. Thank you. And all the rest. So I think this. Hello. Yes, sir. Yes, can you please repeat the question, please? Yes, so as I was saying, just one of the specialty charges part. As your share of Congo in total revenue continues to rise, how are we looking at your specialty charges as a percentage of Congo revenue a couple of years down the line?
Yatharth Tyagi
Specifically we have not seen that way. But if you see that with the 70% revenue being contributed by this Congo, I believe, I think that’s. And then we will be having a. Probably the higher expenditure. I mean that that’s there. Right? But as such, if you ask me, we have not not seen that way. That’s how much in a percentage of these facilities and how much percentage of the expenditure of our Congo? We have not seen it. But yes, you can extrapolate in that way. Because if 70 revenue contributed by this thing and their more in high end surgeries you do. Right. Where we do transplant and others you do. There is a, there are a good, I mean good percentage of the expenditure. So higher percentage expenditure boards in those super specialities.
Unidentified Participant
Okay. Right.
Amit Kumar Singh
For last five years if I take it is in the range of 40 to 45%. So do we expect to be in. Similar range or on the higher end? Some 5% higher would be a right estimation but not significantly higher than that. Okay, great.
Unidentified Participant
Thank you. And all the very best.
operator
Thank you. Thank you. The next question is from the line of uncle from Invest. Please proceed.
Unidentified Participant
Yeah, I had this one question on the trade receivable side that trade receivables have been higher. So anything you can just guide out on that.
Amit Kumar Singh
I think lastly we were quite happy with the OCF conversion the company has done. You know we had a cash conversion of around 68 years ago. So you know, even with high receivables, the important part is that we are receiving that money. Yes, the new business that is generated has also gone into receivables. But the way it happened last year, this year we are on the similar trend. So Q1 itself we have seen good receivable position as far as the money that is inflowing to the company. And over the course of next few years when the government business comes down in the tune of 25% that’s where you could expect the days an absolute number of receivables to also come down.
But more important for us is that the money that is being, you know, generated has been received by the company and we are happy with that progress for the quarter as well.
Unidentified Participant
Understood. Like so far, FY26, like anything that we can assume.
Yatharth Tyagi
I think I’ve already mentioned for H1 the number of receivable days that we do expect and I think for the whole year could be on a similar trend also.
Unidentified Participant
Understood. Yeah. So that’s it from mine. Thank you so much.
operator
Thank you. The next question is from the line of Sumit Gupta from Centrum. Please proceed.
Unidentified Participant
Hi, just one clarification on the tax rate. So divided from 25 to 26% or is it still 24%?
Pankaj Prabhakar
25.6, 25.67%.
Unidentified Participant
How, how much do you expect for 26 on a full year basis?
Pankaj Prabhakar
It’s coming down 26% on a full year basis.
Unidentified Participant
Okay, good. Thank you.
operator
Thank you. The next question is from the line of the drugs from MB Investment. Please proceed.
Unidentified Participant
Hi, my question is what is what. Steps is the board taking to you. Know, improve the corporate governance to your peers compared peers like Max or Apollo? And my question to you is what is your outlook for expansion strategy in nature markets, in nature cities like you have in Jhansi volume Agra? What is your expansion strategy there? If you could share some light on.
Yatharth Tyagi
That, that’d be great. Your first question is as I already talked about in our comments, we have onboarded BDO as a statutory auditor, you know who would be taking over and the existing auditors have accepted the resignation. So BDO being appointed a statutory auditor as well as Deloitte has been appointed as an internal auditor from last few quarters and we have insights and improving our operational efficiency through Deloitte is concerned. As far as the second question in terms of our expansion geographies are concerned, I think for us worked out good because it was one of our, you know, good ROI RC opportunity that we saw going forward you would like to remain in bigger cities? We would not like to experiment much with TF3 cities.
Maybe you know, NCR and you know, capital cities of the big states is where we would like to be because we see good growth in terms of paying potential in rpop in those cities. And that’s what we would like to explore more. That’s why if you see post Jhansi we have quite three hospitals that are in New Delhi and Faridabad. So this sort of reflects is an example of the strategy that the one which we are approaching forward with.
Unidentified Participant
All right, just to follow up, when do you think that on an average level the group can, you know, achieve a average occupancy of upwards of 75%.
Yatharth Tyagi
That’s what I was about to say because we are constantly adding up new beds, right? So that’s why the group level only we can talk about is buying the new hospital. So I think in couple of years our existing hospitals should be at a group level of occupancy of close to 75%.
Unidentified Participant
All right, thank you. That answers my question.
operator
Thank you. The next question is from the line of Mohammed Patel from Edelweiss Public Alternatives. Please proceed.
Unidentified Participant
So how are we going to fund this capex?
Yatharth Tyagi
So we already have a cash position as we talked about up around 300 crores as we speak today the company is sitting on zero debt. So that is an option the company will explore in the future. And thirdly, you know we will be having good internal accuracy. So the capex that we have talked about is a spread across the years, right? It’s not that immediately we do require something. So I think the company is quite capable of funding it through the internal accuracy, the debt, as well as the cash position that we currently sit on.
Unidentified Participant
Okay, thank you.
operator
Thank you. Due to time constraints, that was the last question. I now hand the conference over to Mr. Aman. Over to you, sir.
Aman Vishwakarma
Thank you. On behalf of Select Capital Client Client Group, we thank all the participants for your valuable time and especially the entire team of hospitals and trauma care services ltd. Before we close the call, I would like to hand it over to Mr. Tagi for his closing comments. Over to you, Mr. Tagi.
Yatharth Tyagi
Thank you. Thank you everyone for participating in earning calls for quarter one FY26. And thanks for your questions.
operator
Thank you. On behalf of Philip Capital India Private Limited. That concludes the conference. Thank you for joining us. And you may not disconnect your line.